Search clinical trials for: Northera (Droxidopa)
Total 63 results
-
Alberto Espay, MD, MScLundbeck LLCCompletedOrthostatic Hypotension | Idiopathic Parkinson DiseaseUnited States
-
New York Medical CollegeLundbeck LLCActive, not recruitingPostural Tachycardia Syndrome (POTS) | Fainting | Vasovagal Syncope (VVS)United States
-
Colorado Springs Neurological AssociatesH. Lundbeck A/SCompletedParkinson's DiseaseUnited States
-
H. Lundbeck A/SCompletedSymptomatic Neurogenic Orthostatic HypotensionUnited States
-
Chelsea TherapeuticsWithdrawnGait Disorders, NeurologicUnited States, Canada
-
Stephen G. Kaler, MDRecruitingMenkes Disease | Occipital Horn SyndromeUnited States
-
NYU Langone HealthWithdrawn
-
St. Joseph's Hospital and Medical Center, PhoenixH. Lundbeck A/S; Arizona State UniversityUnknownParkinson Disease | Falls PatientUnited States
-
The Cooper Health SystemTerminatedA Randomized, Double-Blind, Placebo-Controlled Study of Droxidopa for Fatigue in Parkinson's DiseaseFatigue | Parkinson Disease | ParkinsonismUnited States
-
Loma Linda UniversityH. Lundbeck A/SWithdrawnParkinson Disease | Multiple System Atrophy | Progressive Supranuclear PalsyUnited States
-
William Ondo, MDLundbeck LLCCompletedParkinson Disease | Neurogenic Orthostatic HypotensionUnited States
-
James J. Peters Veterans Affairs Medical CenterNew York State Department of HealthCompletedHypotension | Spinal Cord Injuries | Hypotension, OrthostaticUnited States
-
Chelsea TherapeuticsChiltern International Inc.CompletedPrimary Autonomic Failure | Dopamine Beta Hydroxylase Deficiency | Symptomatic Neurogenic Orthostatic Hypotension (NOH) | Non-diabetic NeuropathyUnited States, Australia, Canada, New Zealand
-
St. Joseph's Hospital and Medical Center, PhoenixArizona State UniversityUnknownParkinson DiseaseUnited States
-
Chelsea TherapeuticsCompletedParkinson's Disease | Orthostatic HypotensionUnited States
-
Icahn School of Medicine at Mount SinaiCompletedShy-Drager Syndrome | Orthostatic HypotensionUnited States
-
Vanderbilt UniversityApproved for marketing
-
University Hospital, ToulouseCompletedMultiple System AtrophyFrance
-
Chelsea TherapeuticsCompletedQTc IntervalUnited States
-
Vanderbilt University Medical CenterRecruitingParkinson Disease | Multiple System Atrophy | Orthostatic Hypotension | Pure Autonomic Failure | Autonomic FailureUnited States
-
Chelsea TherapeuticsCompletedMultiple System Atrophy | Neurogenic Orthostatic Hypotension | Dopamine Beta Hydroxylase Deficiency | Non-Diabetic Autonomic NeuropathyUnited States, Australia, Canada, New Zealand
-
Douglas Mental Health University InstituteNational Alliance for Research on Schizophrenia and DepressionActive, not recruitingDepression, Bipolar | Bipolar Type II DisorderCanada
-
Vanderbilt UniversityNational Heart, Lung, and Blood Institute (NHLBI)TerminatedAutonomic Nervous System Diseases | Orthostatic Hypotension | Orthostatic Intolerance | Dopamine Beta-Hydroxylase DeficiencyUnited States
-
Chelsea TherapeuticsCompletedSymptomatic Neurogenic Orthostatic HypotensionUnited States
-
Chelsea TherapeuticsWithdrawn
-
TSH Biopharm Corporation LimitedTerminated
-
Beth Israel Deaconess Medical CenterNational Heart, Lung, and Blood Institute (NHLBI)TerminatedOrthostatic Intolerance | Postural Orthostatic Tachycardia SyndromeUnited States
-
Bronx VA Medical CenterChelsea TherapeuticsCompletedHypotension | Spinal Cord InjuryUnited States
-
Henry Ford Health SystemUnknownParkinson's Disease | Freezing of Gait | Cognitive Ability, GeneralUnited States
-
Chelsea TherapeuticsChiltern International Inc.CompletedA Clinical Study for Patients With Neurogenic Orthostatic Hypotension (NOH) Using Droxidopa (NOH301)Primary Autonomic Failure | Dopamine Beta Hydroxylase Deficiency | Symptomatic Neurogenic Orthostatic Hypotension (NOH) | Non-diabetic NeuropathyUnited States, Canada
-
National Institute of Neurological Disorders and...TerminatedParkinson Disease | Autonomic Nervous System Diseases | Multiple System AtrophyUnited States
-
Chelsea TherapeuticsCompletedIntradialytic HypotensionUnited States
-
Chelsea TherapeuticsCompletedAttention Deficit Hyperactivity DisorderUnited States
-
Chelsea TherapeuticsCompletedNeurogenic Orthostatic Hypotension | Primary Autonomic Failure | Dopamine Beta Hydroxylase Deficiency | Non-Diabetic Neuropathy
-
Chelsea TherapeuticsTerminatedStudy To Assess The Clinical Benefit Of Droxidopa In Subjects With Chronic Fatigue Syndrome (CFS201)Chronic Fatigue Syndrome | Orthostatic Hypotension | Neurally Mediated Hypotension | Neurogenic Orthostatic HypotensionUnited States
-
Fondazione G.B. Bietti, IRCCSCompletedGlaucoma | Optic Neuropathy, Ischemic | Optic Nerve | Visual Pathway Disorder | Neural ConductionItaly
-
Radboud University Medical CenterGlaxoSmithKlineCompletedInfluenza | Herpes ZosterNetherlands
-
University of NottinghamNorthumbria UniversityCompleted
-
The Canadian College of Naturopathic MedicineNot yet recruiting
-
Chelsea TherapeuticsCompletedFibromyalgiaUnited Kingdom
-
Sanofi Pasteur, a Sanofi CompanyCompleted
-
Mayo ClinicNational Cancer Institute (NCI)CompletedNon-melanomatous Skin Cancer
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2 | HypoglycemiaAustria
-
Sanofi Pasteur, a Sanofi CompanyCompletedHealthy Volunteers | Influenza ImmunizationFrance, Belgium, Germany, Italy, Netherlands, Poland
-
Chinese University of Hong KongCompleted
-
Sanofi Pasteur, a Sanofi CompanyCompletedInfluenzaUnited States, Puerto Rico
-
Mayo ClinicNational Institute of Neurological Disorders and Stroke (NINDS)Suspended
-
GlaxoSmithKlineCompleted
-
Chelsea TherapeuticsTerminatedParkinson's Disease | Pure Autonomic Failure | Dopamine Beta Hydroxylase Deficiency | Symptomatic Neurogenic Orthostatic Hypotension | Multiple Systems AtrophyUnited States